ACASTI PHARMA INC
CL A · CUSIP 00430K865
1
institutional holders
20
shares reported held*
$0reported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q4 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2023 | 13 |
| Q4 2023 | 10 |
| Q1 2024 | 11 |
| Q2 2024 | 13 |
| Q3 2024 | 12 |
| Q4 2024 | 0 |
| Q1 2025 | 0 |
| Q2 2025 | 0 |
| Q3 2025 | 0 |
| Q4 2025 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2023 | 5 | 6 |
| Q1 2024 | 5 | 4 |
| Q2 2024 | 7 | 3 |
| Q3 2024 | 3 | 6 |
| Q4 2024 | 0 | 12 |
Biggest buyers
| Motiv8 Investments LLC | New | +20 |
Biggest sellers
| None |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| ADAR1 Capital Management, LLC 13G · institution -0.1 pts · filed 2025-11-14 | 9.9% |
Holders, Q4 2025
| Manager | Shares | Change |
|---|---|---|
| Motiv8 Investments LLC 0.00% of their portfolio | 20 $0 | New |